Nivolumab with or without nab-Paclitaxel in previously treated, advanced stage, non-small cell lung cancer: a randomized Phase II study
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Alliance Foundation Trials, LLC
Start Date
June 2, 2017
End Date
May 30, 2018
Administered By
Duke Cancer Institute
Awarded By
Alliance Foundation Trials, LLC
Start Date
June 2, 2017
End Date
May 30, 2018